24 results
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
of its obligations hereunder and in connection with the transactions contemplated hereby, including without limitation (i) all expenses incident
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
defaulting Underwriter pursuant to Section 10 hereof, the Company hereby agrees to pay all costs and expenses incident to the performance of its obligations … in connection with this Agreement or the Offering; and (viii) the reasonable and documented fees and expenses incident to the performance
8-K
h187u
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
dsui45krn y3
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
8-K/A
EX-99.2
cy10 ary0k5jl2h7o
26 Jun 20
Other Events
5:08pm
8-K
bya1fxn 446c89v1v3ax
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.3
t2s557qdbbpla5b6x4b
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-14.1
myh7dtd srae4v
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
tjygp5of67mjq 0s
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
66h1hct1
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
de02c6
6 Mar 20
Preliminary proxy related to merger
5:32pm
8-K
EX-1.1
n2zk4frc
9 Nov 18
Entry into a Material Definitive Agreement
5:10pm